ofloxacin + doxycycline

Ofloxacin + doxycycline is a combination of two oral antibiotics, each with a distinct mechanism of action. Ofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. Doxycycline is a tetracycline-class antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit in bacteria. This combination may be used in clinical practice for synergistic or broadened antibacterial coverage against certain infections where both drugs are indicated or when resistance patterns necessitate dual therapy. Both agents are active against various Gram-positive and Gram-negative bacteria and have been studied individually and together (in vitro) for their efficacy against pathogens such as *Chlamydia trachomatis*, *Ureaplasma urealyticum*, *Staphylococcus aureus*, *Escherichia coli*, *Klebsiella pneumoniae*, and *Pseudomonas aeruginosa*[4][5][9]. The combination has also been explored in the management of Q fever endocarditis[7].